ClinConnect ClinConnect Logo
Search / Trial NCT05356962

STOP? II: Testing of a Toolbox for Structured Communication in the Operating Room

Launched by INSEL GRUPPE AG, UNIVERSITY HOSPITAL BERN · Apr 26, 2022

Trial Information

Current as of September 26, 2025

Recruiting

Keywords

Communication Briefing Intervention Operating Room Surgery

ClinConnect Summary

The STOP? II trial is studying how a special communication method called the StOP?-protocol can improve discussions among surgical teams during operations and how it affects patient outcomes, such as survival rates after surgery. This protocol involves a structured briefing before surgery that aims to ensure everyone is on the same page, which could lead to better results for patients.

To participate in this study, surgeons must be board-certified and specialize in certain types of surgery, such as general or gynecological surgery. Patients who are eligible for this trial are those who will be operated on by these surgeons during specific times and have given general consent for their health data to be used. However, patients must be at least 18 years old and not have had a surgery at the same location in the last 30 days. If you decide to participate, you can expect that the surgical team will follow a structured communication process during your operation, which researchers hope will lead to improved outcomes.

Gender

ALL

Eligibility criteria

  • For the clusters (surgeons)
  • Inclusion Criteria:
  • Board-certified surgeons with specialization in one of the following disciplines: general, visceral, thoracic, vascular surgery, surgical urology, or gynecology.
  • Exclusion Criteria:
  • Surgeons who are already performing StOP?-protocol. (Potentially, surgeons who took part in the first study (StOP-I) may still perform StOP?).
  • Surgeon who were previously enrolled in the StOP?-II trial (this is relevant for surgeons who move or rotate between departments/hospitals and might therefore be working at different participating sites).
  • For the patients:
  • Inclusion criteria:
  • Patients operated by cluster surgeons during the cluster-specific time period
  • General consent from the patients, allowing the use of healthcare-related data that are the result of the patient's treatment. In case no written document from the general consent is available despite documented efforts of the participating center, article 34 HRA (Swiss law) will be applied, allowing the use of the healthcare-related patient data.
  • Exclusion criteria:
  • Patient age below 18 years
  • Previous operation at the same site up to 30 days prior the index operation
  • Procedures not done in operating rooms but in outpatient clinics, on wards, etc.
  • Mainly diagnostic endoscopic procedures (e.g. colonoscopy, gastroscopy, bronchoscopy)
  • Percutaneous interventions (e.g., transurethral interventions)
  • Documented refusal for the use of healthcare related data

About Insel Gruppe Ag, University Hospital Bern

Insel Gruppe AG, the umbrella organization for the University Hospital Bern, is a leading healthcare provider in Switzerland, renowned for its commitment to advancing medical research and patient care. As a key player in clinical trials, Insel Gruppe AG integrates cutting-edge scientific inquiry with clinical excellence, facilitating innovative studies that span a wide range of medical disciplines. The institution prioritizes collaboration with academic partners and industry stakeholders to enhance the understanding of diseases and develop effective treatment options, ultimately aiming to improve patient outcomes and contribute to the global medical community.

Locations

Liestal, Bl, Switzerland

Innsbruck, Austria

Chur, Gr, Switzerland

Schlieren, Zh, Switzerland

Neuchâtel, Switzerland

Bern, Be, Switzerland

Lausanne, Vaud, Switzerland

Fribourg, Fr, Switzerland

Frauenfeld, Thurgau, Switzerland

Winterthur, Zh, Switzerland

Zürich, Zh, Switzerland

Patients applied

0 patients applied

Trial Officials

Guido Beldi, MD

Principal Investigator

Department of Visceral Surgery and Medicine, Berne University Hospital, University of Berne, Berne, Switzerland

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials